Spex Capital

Spex Capital is a London-based investment management firm established in 2021, focusing on the digital health and medical technology sectors. The firm specializes in identifying, supporting, and investing in early-stage ventures that aim to introduce disruptive innovations within global healthcare systems. With a unique partnership with the NHS and connections to a broad international healthcare ecosystem—including embassies, trade bodies, universities, and hospitals—Spex Capital seeks to commercialize and scale promising digital health companies. By leveraging these relationships, the firm aims to source and advance high-quality technologies that can improve healthcare delivery worldwide.

Claudio D’Angelo

Managing Director

Filippo Falaschi

Investor

Bradley Hardiman

Investor

Tobias Krauss

Chairman of Supervisory Board

Charlotte McIntyre

Investor

Eugene Ong

Investor

Francis Pollen

Investor

Alok Prasad

Investor

Diva Tommei Ph.D

General Partner and Investment Committee Member

Matt Varughese

Investor

8 past transactions

Knokcare

Seed Round in 2020
Knokcare is an app-based healthcare platform that connects patients with doctors and independent medical professionals through on-demand video consultations, house visits, and in-person appointments. The platform integrates remote and in-person care within a single application, using an AI chatbot to help patients self-assess, guide them to appropriate video or in-home visits, and coordinate with hospitals when necessary. It aims to streamline care for patients while improving efficiency for health systems by routing urgent cases to hospital services and securely managing patient records to protect privacy. The service supports medical institutions and providers by facilitating real-time communication, remote assessments, and convenient access to care.

Skin Analytics

Series A in 2020
Skin Analytics is a London-based company that uses smartphone imagery and artificial intelligence to create a digital history of a patient’s skin, enabling clinicians to measure changes over time, assess treatment options, and support early detection of skin cancers such as melanoma. Its platform analyzes images of moles and skin lesions to monitor progression, standardize patient management, and potentially reduce diagnostic wait times, with applications spanning consumer skin health and clinical settings, including use within the NHS.

Log my Care

Seed Round in 2020
Log my Care is a provider of electronic care planning and management software aimed at enhancing coordination and communication within care environments. The platform allows care providers to transition from traditional paper-based recording to a streamlined electronic system. It features a shared to-do log that informs care employees of their tasks, while also generating printable reports on activity performance. This functionality enables care managers to maintain oversight of their services efficiently, ultimately facilitating better operational management and improved care delivery.

MediShout

Pre Seed Round in 2020
Founded in London in 2013, MediShout develops a cloud-based digital platform that enhances operational efficiencies within healthcare settings. Its technology connects staff, systems, machines, and workflows, improving efficiency and patient care. The platform offers features such as two-way conversations, instant feedback, integration of logistical departments, and AI-driven predictive analytics.

Firza

Seed Round in 2020
Firza Ltd is a healthcare advisory company based in London, UK, specializing in technology-enabled workforce solutions for the healthcare sector. Founded in 2014 and formerly known as Syd Lee Limited, Firza provides a variety of services including medication reviews, prescription reauthorizations, document management, and support for care homes and prisons. The company aims to modernize healthcare operations by leveraging robotic process automation and artificial intelligence, delivering tailored solutions to NHS organizations, general practice teams, and pharmacies. Firza's expertise in primary care allows for quick mobilization and the development of effective strategies that address the unique needs of healthcare providers, ultimately simplifying their daily operations and enhancing service delivery.

LiveSmart

Seed Round in 2020
LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.

LiveSmart

Seed Round in 2019
LiveSmart U.K. Limited is a health assessment services provider based in London, established in 2016. The company specializes in a comprehensive range of health and wellness assessments, focusing on areas such as cardiovascular health, liver and kidney function, bone health, and mental health. It offers home blood tests, including vitamin D deficiency tests, and provides digital health programs that encompass pathology-based assessments, dietitian and health coach solutions, and educational resources. LiveSmart also supplies blood pressure monitors to help mitigate health risks. Its flagship solution enables employees to monitor and enhance their health, aiming to reduce sickness absence, improve long-term health outcomes, and boost productivity for businesses. The company has adapted to evolving health needs by supplying antibody tests and supporting both small businesses and large corporate clients through its established platform.

Skin Analytics

Seed Round in 2019
Skin Analytics is a London-based company that uses smartphone imagery and artificial intelligence to create a digital history of a patient’s skin, enabling clinicians to measure changes over time, assess treatment options, and support early detection of skin cancers such as melanoma. Its platform analyzes images of moles and skin lesions to monitor progression, standardize patient management, and potentially reduce diagnostic wait times, with applications spanning consumer skin health and clinical settings, including use within the NHS.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.